Keyphrases
Cardiopulmonary Resuscitation
100%
Arginine Vasopressin
100%
Vasopressin
100%
Vasodilatory Shock
100%
Epinephrine
66%
Adult Patients
33%
Ventricular Fibrillation
33%
Ventricular Arrhythmia
33%
Austria
16%
Germany
16%
Clinical Data
16%
Adverse Effects
16%
Continuous Infusion
16%
Receptor-mediated
16%
Vasopressors
16%
Vital Organs
16%
Cardiac Failure
16%
Switzerland
16%
Catecholamines
16%
Arterial Blood Pressure
16%
Myocardial Oxygen Consumption
16%
Cardiocirculatory
16%
Asystole
16%
Organ Blood Flow
16%
Perfusion Defect
16%
Cerebral Oxygenation
16%
Out-of-hospital Cardiac Arrest
16%
Ventilation-perfusion Ratio
16%
Large Trials
16%
New International
16%
Post-resuscitation Myocardial Dysfunction
16%
Pulseless Electrical Activity
16%
Epinephrine Use
16%
Neurological Recovery
16%
Resuscitation Guidelines
16%
Medicine and Dentistry
Shock (Circulatory)
100%
Vasopressin
100%
Argipressin
100%
Resuscitation
100%
Epinephrine
83%
Heart Ventricle Arrhythmia
33%
Ventricular Fibrillation
33%
Heart Failure
16%
Receptor
16%
Adverse Event
16%
Continuous Infusion
16%
Hypertensive Factor
16%
Arterial Pressure
16%
Heart Muscle Oxygen Consumption
16%
Heart Arrest
16%
Organ Blood Flow
16%
Lung Ventilation
16%
Out of Hospital Cardiac Arrest
16%
Pulseless Electrical Activity
16%
Cerebral Blood Flow
16%
Catecholamine
16%
Nursing and Health Professions
Resuscitation
100%
Argipressin
100%
Vasopressin
100%
Epinephrine
83%
Heart Ventricle Fibrillation
33%
Heart Ventricle Arrhythmia
33%
Practice Guideline
16%
Perfusion
16%
Heart Failure
16%
Heart Arrest
16%
Adverse Event
16%
Arterial Pressure
16%
Continuous Infusion
16%
Hypertensive Factor
16%
Receptor
16%
Organ Blood Flow
16%
Out of Hospital Cardiac Arrest
16%
Catecholamine
16%
Pharmacology, Toxicology and Pharmaceutical Science
Vasopressin
100%
Argipressin
100%
Epinephrine
83%
Heart Ventricle Fibrillation
33%
Heart Ventricle Arrhythmia
33%
Heart Failure
16%
Receptor
16%
Heart Arrest
16%
Adverse Event
16%
Hypertensive Factor
16%
Out of Hospital Cardiac Arrest
16%
Catecholamine
16%